Cargando…

Response to Comment on Grimaldi et al. Association of Obstructive Sleep Apnea in Rapid Eye Movement Sleep With Reduced Glycemic Control in Type 2 Diabetes: Therapeutic Implications. Diabetes Care 2014;37:355–363

Detalles Bibliográficos
Autores principales: Mokhlesi, Babak, Grimaldi, Daniela, Van Cauter, Eve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931385/
https://www.ncbi.nlm.nih.gov/pubmed/24558089
http://dx.doi.org/10.2337/dc13-2662
_version_ 1782304657041784832
author Mokhlesi, Babak
Grimaldi, Daniela
Van Cauter, Eve
author_facet Mokhlesi, Babak
Grimaldi, Daniela
Van Cauter, Eve
author_sort Mokhlesi, Babak
collection PubMed
description
format Online
Article
Text
id pubmed-3931385
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-39313852015-03-01 Response to Comment on Grimaldi et al. Association of Obstructive Sleep Apnea in Rapid Eye Movement Sleep With Reduced Glycemic Control in Type 2 Diabetes: Therapeutic Implications. Diabetes Care 2014;37:355–363 Mokhlesi, Babak Grimaldi, Daniela Van Cauter, Eve Diabetes Care Online Letters: Comments and Responses American Diabetes Association 2014-03 2014-02-11 /pmc/articles/PMC3931385/ /pubmed/24558089 http://dx.doi.org/10.2337/dc13-2662 Text en © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Online Letters: Comments and Responses
Mokhlesi, Babak
Grimaldi, Daniela
Van Cauter, Eve
Response to Comment on Grimaldi et al. Association of Obstructive Sleep Apnea in Rapid Eye Movement Sleep With Reduced Glycemic Control in Type 2 Diabetes: Therapeutic Implications. Diabetes Care 2014;37:355–363
title Response to Comment on Grimaldi et al. Association of Obstructive Sleep Apnea in Rapid Eye Movement Sleep With Reduced Glycemic Control in Type 2 Diabetes: Therapeutic Implications. Diabetes Care 2014;37:355–363
title_full Response to Comment on Grimaldi et al. Association of Obstructive Sleep Apnea in Rapid Eye Movement Sleep With Reduced Glycemic Control in Type 2 Diabetes: Therapeutic Implications. Diabetes Care 2014;37:355–363
title_fullStr Response to Comment on Grimaldi et al. Association of Obstructive Sleep Apnea in Rapid Eye Movement Sleep With Reduced Glycemic Control in Type 2 Diabetes: Therapeutic Implications. Diabetes Care 2014;37:355–363
title_full_unstemmed Response to Comment on Grimaldi et al. Association of Obstructive Sleep Apnea in Rapid Eye Movement Sleep With Reduced Glycemic Control in Type 2 Diabetes: Therapeutic Implications. Diabetes Care 2014;37:355–363
title_short Response to Comment on Grimaldi et al. Association of Obstructive Sleep Apnea in Rapid Eye Movement Sleep With Reduced Glycemic Control in Type 2 Diabetes: Therapeutic Implications. Diabetes Care 2014;37:355–363
title_sort response to comment on grimaldi et al. association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications. diabetes care 2014;37:355–363
topic Online Letters: Comments and Responses
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931385/
https://www.ncbi.nlm.nih.gov/pubmed/24558089
http://dx.doi.org/10.2337/dc13-2662
work_keys_str_mv AT mokhlesibabak responsetocommentongrimaldietalassociationofobstructivesleepapneainrapideyemovementsleepwithreducedglycemiccontrolintype2diabetestherapeuticimplicationsdiabetescare201437355363
AT grimaldidaniela responsetocommentongrimaldietalassociationofobstructivesleepapneainrapideyemovementsleepwithreducedglycemiccontrolintype2diabetestherapeuticimplicationsdiabetescare201437355363
AT vancautereve responsetocommentongrimaldietalassociationofobstructivesleepapneainrapideyemovementsleepwithreducedglycemiccontrolintype2diabetestherapeuticimplicationsdiabetescare201437355363